Shares of Cell MedX Corp. (OTCMKTS:CMXC – Get Rating) passed below its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of $0.09 and traded as low as $0.06. Cell MedX shares last traded at $0.06, with a volume of 1,500 shares traded.
Cell MedX Price Performance
The firm’s 50-day simple moving average is $0.09 and its 200 day simple moving average is $0.09.
About Cell MedX
Cell MedX Corp., a biotech company, focuses on the discovery, development, and commercialization of therapeutic and non-therapeutic products for patients with diabetes, Parkinson's disease, high blood pressure, neuropathy, and kidney functions. It develops and manufactures eBalance Pro System for professional use by healthcare practitioners in a clinical setting; and eBalance Home System for home use for general wellness and pain management treatment, which are controlled by the eBalance Console that acts as the central controller for three pre-programmed microcurrent algorithms, including wellness, pain management, and dual.
- Get a free copy of the StockNews.com research report on Cell MedX (CMXC)
- Use The Airbnb Stock Implosion to Your Advantage
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- International Game Technology is Well Worth the Gamble
- Why Lowe’s Is Up And Home Depot Down
- The TJX Companies Could Break Out To New Highs
Receive News & Ratings for Cell MedX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cell MedX and related companies with MarketBeat.com's FREE daily email newsletter.